Bexmarilimab (Synonyms: FP-1305) |
| Catalog No.GC68755 |
Bexmarilimab (FP-1305) es un anticuerpo humanizado anti-CLEVER-1 IgG4 efectivo, con un valor de IC50 de 4.51 nM. Bexmarilimab puede inducir la transición inmunológica del fenotipo M2 al M1 en las células macrofágicas relacionadas con el tumor. Bexmarilimab se puede utilizar en investigaciones sobre cáncer.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2259301-27-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Bexmarilimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Bexmarilimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *